A Novel Chitosan-Gossypol Based Nanocarrier for Anticancer Curcumin Drug Delivery = A Novel Chitosan-Gossypol Based Nanocarrier for Anticancer Curcumin Drug Delivery

다국어 초록 (Multilingual Abstract)

Gossypol chitosan (GPCS) nanoparticles have been successfully synthesized at the size of 20-40 nm through amidation process to forming base shift of polymer chains of chitosan using gossypol as a crosslinking agent. Their structure was confirmed by Fourier Transformed Infra Red (FT-IR) spectra. Morphology, stability, loading and releasing efficiency of GPCS and Cur/GPCS (Cur stands for curcumin) were thoroughly investigated by Field Emission Scanning Electron Microscopy (FESEM), FT-IR, Ultra Violet-Visible spectrophotometry (UV-Vis) and High Resolve Photoluminescence System (HRPLS). The obtained nanocarrier exhibited an excellent solubility for Cur anticancer drug as well as high stability for in vitro studies. An intensive fluorescence, allowing drug monitor/delivery, was achieved. Drug release profile was also studied. GPCS, therefore, could be considered to be a potential drug carrier for therapeutic treatment.

참고문헌 (Reference)

1 Przybylski, P, "X-ray, FT-IR, ESI MS and PM5 studies of schiff base of gossypol with allylamine and its complexes with alkali metal cations and perchlorate anion" 19 : 983-995, 2008

2 Wolter, K.G, "Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2" 14 : 1605-1616, 2007

3 Hron, R.J, "The potential commercial aspects of gossypol" 76 : 1315-1319, 1987

4 서영준, "The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease" Springer 595-, 2007

5 Donadel, K, "Synthesis and characterization of the iron oxide magnetic particles coated with chitosan biopolymer" 28 : 509-514, 2008

6 Brzezinski, B, "Spectroscopic study of gossypol-lanthanide cation complexes in acetonitrile solution" 435 : 275-279, 1997

7 Fan, M, "Preparation and structure of chitosan soluble in wide pH range" 78 : 66-71, 2009

8 Li, G.Y, "Preparation and properties of magnetic Fe3O4–chitosan nanoparticles" 466 : 451-456, 2008

9 Risbud, M.V, "Polyacrylamide-chitosan hydrogels: in vitro biocompatibility and sustained antibiotic release studies" 7 : 69-75, 2000

10 "Pharmaceutical applications of chitosan and derivative poly-saccharides, In Structural diversity and functional versatility 2 nded" Marcel Dekker Publishing 661-677, 2005

11 Tran, L.D, "Nanosized magnetofluorescent Fe3O4–curcumin conjugate for multimodal monitoring and drug targeting. Colloids and Surfaces A: Physicochem" 371 : 104-112, 2011

12 Zhang, M, "Molecular mechanism of gossypol- induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem" 66 : 93-103, 2003

13 Li, G.Y, "Kinetics of adsorption of Saccharomyces cerevisiae mandelated dehydrogenase on magnetic Fe3O4–chitosan nanoparticles" 320 : 11-18, 2008

14 Socrates, G, "Infrared characteristic group frequencies" John Wiley & Sons 1994

15 Yuan, M, "Identification of curcumin derivatives as human glyoxalase I inhibitors: A combination of biological evaluation, molecular docking, 3D-QSAR and molecular dynamics simulation studies" 19 : 1189-1196, 2011

16 Vander, J.D, "Gossypol: Prototype of inhibitors targeted to dinucleotide folds" 7 : 479-498, 2000

17 Macoskaa, J.A, "Gossypol promotes the apoptosis of bladder cancer cells in vitro" 58 : 323-331, 2008

18 Brzezinski, B, "Fourier transform infrared study on the identification of gossypol tautomers" 239 : 23-31, 1990

19 Dat, R.K, "Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells" 6 : 153-160, 2010

20 Anitha, A, "Efficient water soluble Ocarboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells" 83 : 452-461, 2011

21 Wang, N.G, "Effect of (−)- and (+)-gossypol on fertility in male rats" 20 : 21-24, 1987

22 Yew, S.Y, "Design of single peptidesfor self-assembled conduction channels" 22 : 560-566, 2011

23 Przybylski, P, "Crystal structure of schiff base derivative of gossypol with 3,6,9-trioxa-decylamine" 655 : 293-300, 2003

24 Morimoto, M, "Control of function of chitin and chitosan by chemical modifications" 14 : 205-222, 2002

25 Enrico, M.A, "Chitosan-based delivery systems for protein therapeutics and antigens" 63 : 59-82, 2010

26 Sinha, V.R, "Chitosan microspheres as a potential carrier for drugs" 274 : 1-33, 2002

27 Kumar, M.N.V, "Chitosan chemistry and pharmaceutical perspectives" 104 : 6017-6084, 2004

28 Illum, L, "Chitosan as a delivery system for the trans-mucosal administration of drug poly-saccharides, In Structural diversity and functional versatility 2 nded" Marcel Dekker Publishing 643-660, 2005

29 Roberts, G.A.F, "Chitin chemistry" Chitin chemistry MacMillan Publishing Co. Inc 1992

30 Rinaudo, M, "Chitin and chitosan: properties and applications" 31 : 603-632, 2006

31 Le Blanc, M, "An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines" 46 : 551-555, 2002

32 Zhai, G, "A liposomal delivery vehicle for the anticancer agent gossypol" 28 : 2801-2805, 2008

33 Przybylski, P, "13C,15N CP-MAS as well as FT-IR studies of gossypol derivatives with aro- matic substituents in solid" 826 : 150-155, 2007

34 Huang, J.D, "(1E,4E)-1,5-Bis(2,6-difluorophenyl)penta-1,4-dien-3-one" 67 : 758-767, 2011